AAAAAA

   
Results: 1-25 | 26-49
Results: 1-25/49
A RETROSPECTIVE CHART REVIEW OF UNCONTROLLED USE OF METFORMIN AS AN ADD-ON THERAPY IN TYPE-2 DIABETES
Authors: JOHNSON M KROSNICK A CARSON P MCDADE AM LARAWAY K
Citation: M. Johnson et al., A RETROSPECTIVE CHART REVIEW OF UNCONTROLLED USE OF METFORMIN AS AN ADD-ON THERAPY IN TYPE-2 DIABETES, Clinical therapeutics, 20(4), 1998, pp. 691-698
EDITORIAL COMMENT
Authors: KROSNICK A
Citation: A. Krosnick, EDITORIAL COMMENT, Clinical therapeutics, 19(5), 1997, pp. 867-867
EDITORIAL COMMENT
Authors: KROSNICK A
Citation: A. Krosnick, EDITORIAL COMMENT, Clinical therapeutics, 19(4), 1997, pp. 603-603
EDITORIAL COMMENT
Authors: KROSNICK A
Citation: A. Krosnick, EDITORIAL COMMENT, Clinical therapeutics, 19(3), 1997, pp. 367-368
EDITORIAL COMMENT
Authors: KROSNICK A
Citation: A. Krosnick, EDITORIAL COMMENT, Clinical therapeutics, 19(2), 1997, pp. 185-186
EDITORIAL COMMENT
Authors: KROSNICK A
Citation: A. Krosnick, EDITORIAL COMMENT, Clinical therapeutics, 19(1), 1997, pp. 2-3
REDUCTION OF POSTPRANDIAL HYPERGLYCEMIA AND FREQUENCY OF HYPOGLYCEMIAIN IDDM PATIENTS ON INSULIN-ANALOG TREATMENT
Authors: ANDERSON JH BRUNELLE RL KOIVISTO VA PFUTZNER A TRAUTMANN ME VIGNATI L DIMARCHI R BOWEN KM CAMERON DP NANKERVIS AJ ROBERTS AP ZIMMET P BORKENSTEIN MH SCHERNTHANER G WALDHAUSL WK DELEEUW IH FERY F SCHEEN A SOMERS G FETTES IM TILDESLEY HD TOTH EL VIIKARI J ALTMAN JJ BOUGNERES PF DROUIN P FOSSATI P GUILLAUSSEAU PJ MARECHAUD E RIOU JP SELAM JL VIALETTES PB BEYER J FEDERLIN K FUSSGANGER RD GRIES FA JASTRAM HU KOOP I LANDGRAF R ROSAK C SCHATZ H SCHULZESCHLEPPINGHOFF B SEIF FJ STOECKMANN F KARASIK A WEITZMAN S ANDREANI D BOMPIANI G CREPALDI G GIORGINO R GRECO AV LAURO R MAINGAY D MANCINI M MENZINGER G MUGGEO M PAGANO G SACCA L TIENGO A VIGNERI R ERKELENS DW JANSSENS EN LEKKERKERKER JF SPIJKER AJ DANIELS AR FOLLING I BONNICI FB MOLLENTZE WF MOORE R OMAR MA ROBERTSON LI ASTORGA R DELEIVA A JARA A VAZQUEZ JA VILLARDELL E AGARDH CD ALEXANDER WD BARNETT AH CASSAR J HITMAN GA KESSON CM OHARE JP SHAW KM WALES JK ARSLANIAN S BASTYR EJ BLEVINS TC BOYCE PA BRINK SJ CLARKE DH DECLUE T GARBER AJ GUTHRIE RA JOHNSON DG KROSNICK A LINARELLI LG MCCULLOCH DK MEZITIS NH RASKIN P REEVES ML ROSENBLATT S SCHIMEL D SKYLER JS SONNENBERG GE WHITEHOUSE FW ZIMMERMAN B
Citation: Jh. Anderson et al., REDUCTION OF POSTPRANDIAL HYPERGLYCEMIA AND FREQUENCY OF HYPOGLYCEMIAIN IDDM PATIENTS ON INSULIN-ANALOG TREATMENT, Diabetes, 46(2), 1997, pp. 265-270
A DOSE-RESPONSE STUDY OF GLIMEPIRIDE IN PATIENTS WITH NIDDM WHO HAVE PREVIOUSLY RECEIVED SULFONYLUREA AGENTS
Authors: GOLDBERG RB HOLVEY SM SCHNEIDER J BANSAL S BLONDE L BODEN G BRANSOME ED CLARK C CLARKE D DAVIS M DAVIS S GERICH J GOLDBERG R HAAG B HENDLER R JOSSE RG JOVANOVICPETERSON L KARAM JH KENNEDY F KILO C KLACHKO D KNOPF RF KOLTERMAN O KROSNICK A LEITER LA LESLIE C MALONE JK MEENAN A METZGER B MORRISON AD RASKIN P REEVES M RENDELL M SAUDEK C SCHWARTZ S SKOR D TUNG PC
Citation: Rb. Goldberg et al., A DOSE-RESPONSE STUDY OF GLIMEPIRIDE IN PATIENTS WITH NIDDM WHO HAVE PREVIOUSLY RECEIVED SULFONYLUREA AGENTS, Diabetes care, 19(8), 1996, pp. 849-856
GLIMEPIRIDE, A NEW ONCE-DAILY SULFONYLUREA - A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY OF NIDDM PATIENTS
Authors: ROSENSTOCK J SAMOLS E MUCHMORE DB SCHNEIDER J ABELOVE WA ASPLIN CM BERGSTROM RW BERHANU P BOROWSKI GD BROWNING GV COMSTOCK JP FRIEDMAN NM GOLLAPUDI GM GRABER AL GUTHRIE RA HENSON BE HERSHON KS KROSNICK A LEVIN SR LEVY P LOCK JP LODEWICK PA MERSEY JH MICHIE DD MATHER SR MUSEY VC PALMER JP PETERS PJ POULOS JT PRENDERGAST JJ REYNOLDS LR ROBERTS VL ROSENBLATT S ROSENTHAL AR CAVANAUGH JJ SCHNEIDER SH SNYDER JW SWEET RA VESTAL RE
Citation: J. Rosenstock et al., GLIMEPIRIDE, A NEW ONCE-DAILY SULFONYLUREA - A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY OF NIDDM PATIENTS, Diabetes care, 19(11), 1996, pp. 1194-1199
EDITORIAL COMMENT
Authors: KROSNICK A
Citation: A. Krosnick, EDITORIAL COMMENT, Clinical therapeutics, 18(6), 1996, pp. 1005-1005
A REVIEW OF LONG-TERM STUDIES EVALUATING THE EFFICACY OF WEIGHT-LOSS IN AMELIORATING DISORDERS ASSOCIATED WITH OBESITY - EDITORIAL COMMENT
Authors: KROSNICK A
Citation: A. Krosnick, A REVIEW OF LONG-TERM STUDIES EVALUATING THE EFFICACY OF WEIGHT-LOSS IN AMELIORATING DISORDERS ASSOCIATED WITH OBESITY - EDITORIAL COMMENT, Clinical therapeutics, 18(6), 1996, pp. 1036-1036
TREATMENT REGIMENS FOR PATIENTS WITH TOXOPLASMIC ENCEPHALITIS - EDITORIAL COMMENT
Authors: KROSNICK A
Citation: A. Krosnick, TREATMENT REGIMENS FOR PATIENTS WITH TOXOPLASMIC ENCEPHALITIS - EDITORIAL COMMENT, Clinical therapeutics, 18(6), 1996, pp. 1057-1057
UNTITLED
Authors: KROSNICK A
Citation: A. Krosnick, UNTITLED, Clinical therapeutics, 18(5), 1996, pp. 789-789
EDITORIAL COMMENT
Authors: KROSNICK A
Citation: A. Krosnick, EDITORIAL COMMENT, Clinical therapeutics, 18(4), 1996, pp. 561-561
COMPARATIVE EFFICACY OF ORAL AND INTRAVENOUS GRANISETRON FOR THE PREVENTION OF ACUTE CHEMOTHERAPY-INDUCED EMESIS - EDITORIAL COMMENT
Authors: KROSNICK A
Citation: A. Krosnick, COMPARATIVE EFFICACY OF ORAL AND INTRAVENOUS GRANISETRON FOR THE PREVENTION OF ACUTE CHEMOTHERAPY-INDUCED EMESIS - EDITORIAL COMMENT, Clinical therapeutics, 18(4), 1996, pp. 577-577
CHANGING ANTIPSYCHOTIC MEDICATION - GUIDELINES ON THE TRANSITION TO TREATMENT WITH RISPERIDONE - EDITORIAL COMMENT
Authors: KROSNICK A
Citation: A. Krosnick, CHANGING ANTIPSYCHOTIC MEDICATION - GUIDELINES ON THE TRANSITION TO TREATMENT WITH RISPERIDONE - EDITORIAL COMMENT, Clinical therapeutics, 18(4), 1996, pp. 591-591
EDITORIAL COMMENT
Authors: KROSNICK A
Citation: A. Krosnick, EDITORIAL COMMENT, Clinical therapeutics, 18(3), 1996, pp. 359-359
EDITORIAL COMMENT
Authors: KROSNICK A
Citation: A. Krosnick, EDITORIAL COMMENT, Clinical therapeutics, 18(3), 1996, pp. 372-372
EDITORIAL COMMENT
Authors: KROSNICK A
Citation: A. Krosnick, EDITORIAL COMMENT, Clinical therapeutics, 18(3), 1996, pp. 391-391
UNTITLED - COMMENT
Authors: KROSNICK A
Citation: A. Krosnick, UNTITLED - COMMENT, Clinical therapeutics, 18(2), 1996, pp. 213-213
UNTITLED - COMMENT
Authors: KROSNICK A
Citation: A. Krosnick, UNTITLED - COMMENT, Clinical therapeutics, 18(2), 1996, pp. 228-228
UNTITLED - COMMENT
Authors: KROSNICK A
Citation: A. Krosnick, UNTITLED - COMMENT, Clinical therapeutics, 18(1), 1996, pp. 1-1
UNTITLED - COMMENT
Authors: KROSNICK A
Citation: A. Krosnick, UNTITLED - COMMENT, Clinical therapeutics, 18(1), 1996, pp. 35-35
UNTITLED - COMMENT
Authors: KROSNICK A
Citation: A. Krosnick, UNTITLED - COMMENT, Clinical therapeutics, 18(1), 1996, pp. 55-55
A PLACEBO-CONTROLLED, DOSE-RESPONSE STUDY OF DEXFENFLURAMINE IN THE TREATMENT OF OBESE PATIENTS
Authors: MARBURY TC ANGELO JE GULLEY RM KROSNICK A SUGIMOTO DH ZELLNER SR
Citation: Tc. Marbury et al., A PLACEBO-CONTROLLED, DOSE-RESPONSE STUDY OF DEXFENFLURAMINE IN THE TREATMENT OF OBESE PATIENTS, Current therapeutic research, 57(9), 1996, pp. 663-674
Risultati: 1-25 | 26-49